YD Bio Limited Ordinary Shares YDES

$4.95 +16.75% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 Insider transaction 2026-10-06 View →
4 Insider transaction 2026-10-06 View →
4 Insider transaction 2026-09-16 View →
4 OWNERSHIP DOCUMENT 2026-09-10 View →
4 Insider transaction 2026-09-08 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-09-01 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-08-11 View →
4 Insider transaction 2026-07-01 View →
4 Insider transaction 2026-07-01 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-05-01 View →
20-F ANNUAL REPORT 2026-04-30 View →
4 Insider transaction 2026-04-02 View →
4 Insider transaction 2026-04-02 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-02-26 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-01-30 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-01-21 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-01-16 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-01-15 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-01-06 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2025-11-17 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2025-09-30 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2025-09-26 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2025-09-19 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2025-08-15 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$4.95
Market Cap
$350.67 million
52-Week Range
$1.70 – $22.00
Average Volume
414K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.